Gianella Facchin Selected Research

Amines

11/2020

Electrochemical, mechanistic, and DFT studies of amine derived diphosphines containing Ru(II)-cymene complexes with potent in vitro cytotoxic activity against HeLa and triple-negative breast cancer cells MDA-MB-231.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianella Facchin Research Topics

Disease

6	Neoplasms (Cancer) 04/2023 - 10/2014
3	Critical Illness (Critically Ill) 07/2011 - 05/2009
3	Inflammation (Inflammations) 07/2011 - 05/2009
3	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 07/2011 - 05/2009
2	Adenocarcinoma 01/2022 - 01/2016
2	Triple Negative Breast Neoplasms 01/2022 - 11/2020
2	Ventilator-Associated Pneumonia 07/2011 - 06/2010
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Healthcare-Associated Pneumonia 07/2011

Drug/Important Bio-Agent (IBA)

4	Cisplatin (Platino)FDA LinkGeneric 04/2023 - 01/2016
3	DipeptidesIBA 01/2023 - 01/2016
3	CopperIBA 01/2022 - 10/2014
3	SeleniumIBA 07/2011 - 05/2009
2	PhenanthrolinesIBA 01/2023 - 01/2022
2	Selenious Acid (Selenite)IBA 07/2011 - 06/2010
1	4-trifluoromethylsalicylic acid (HTB)IBA 01/2022
1	Thymidine Monophosphate (TMP)IBA 01/2022
1	4-cymene (p-cymene)IBA 11/2020
1	pyridineIBA 11/2020
1	CymenesIBA 11/2020
1	AminesIBA 11/2020
1	Cytotoxins (Cytolysins)IBA 11/2020
1	alanylphenylalanine (Ala-Phe)IBA 01/2016
1	phenylalanylalanineIBA 01/2016
1	Glutathione (Reduced Glutathione)IBA 05/2009
1	Biomarkers (Surrogate Marker)IBA 05/2009
1	Glutathione PeroxidaseIBA 05/2009

Therapy/Procedure

1	Length of Stay 06/2010
1	Intravenous Infusions 06/2010